{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:14:42Z","timestamp":1792401282049,"version":"4.4.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1097\/bor.0b013e3282f1ecd4","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T21:56:08Z","timestamp":1236203768000},"page":"100-105","source":"Crossref","is-referenced-by-count":35,"title":["Musculoskeletal syndromes associated with malignancy (excluding hypertrophic osteoarthropathy)"],"prefix":"10.1097","volume":"20","author":[{"given":"Jochanan E","family":"Naschitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itzhak","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210128","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00002281-200101000-00010","article-title":"Rheumatic syndromes: clues to occult neoplasia","volume":"13","author":"Naschitz","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"R2-18-20210128","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00296-005-0005-3","article-title":"Paraneoplastic rheumatic syndromes","volume":"26","author":"Andras","year":"2006","journal-title":"Rheumatol Int"},{"key":"R3-18-20210128","first-page":"293","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc R Soc Med"},{"key":"R4-18-20210128","first-page":"111","article-title":"Autoimmune rheumatic diseases and cancer: evidence of causality?","author":"Villa","year":"2000"},{"key":"R5-18-20210128","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1176\/jnp.13.3.318","article-title":"Applying Bradford Hill's Criteria for Causation to Neuropsychiatry. Challenges and Opportunities","volume":"13","author":"Van Reekum","year":"2001","journal-title":"Neuropsychiatry Clin Neurosci"},{"key":"R6-18-20210128","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"R7-18-20210128","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann Intern Med"},{"key":"R9-18-20210128","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1196\/annals.1361.047","article-title":"Cancer-associated myositis: clinical features and prognostic signs","volume":"1051","author":"Ponyi","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"R10-18-20210128","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1365-2133.2001.04140.x","article-title":"Predicting factors of malignancy in dermatomyositis and polymyositis: a case\u2013control study","volume":"144","author":"Chen","year":"2001","journal-title":"Br J Dermatol"},{"key":"R11-18-20210128","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/01.bor.0000245721.02512.77","article-title":"Cancer and myositis: new insights into an old association","volume":"18","author":"Levine","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"R12-18-20210128","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","article-title":"Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy","volume":"201","author":"Casciola-Rosen","year":"2005","journal-title":"J Exp Med"},{"key":"R13-18-20210128","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ijc.21118","article-title":"Immune responses to DNA mismatch repair enzymes hMSH2 and hPMS1 in patients with pancreatic cancer, dermatomyositis and polymyositis","volume":"116","author":"Okada","year":"2005","journal-title":"Int J Cancer"},{"key":"R14-18-20210128","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10067-005-1130-9","article-title":"Prostate cancer underlying acute, definitive dermatomyositis: successful treatment with radical perineal prostatectomy","volume":"25","author":"Tallai","year":"2006","journal-title":"Clin Rheumatol"},{"key":"R15-18-20210128","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1442-2042.2005.01105.x","article-title":"Successful cure of dermatomyositis after treatment of nonseminomatous testicular cancer","volume":"12","author":"Yoshinaga","year":"2005","journal-title":"Int J Urol"},{"key":"R16-18-20210128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0140-6736(93)92485-C","article-title":"Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies","volume":"341","author":"Darnell","year":"1993","journal-title":"Lancet"},{"key":"R17-18-20210128","first-page":"795","article-title":"Severe necrotic and haemorrhagic edema of the upper limbs revealing remitting seronegative symmetrical synovitis with pitting edema","volume":"133","author":"Guegan","year":"2006","journal-title":"Ann Dermatol Venereol"},{"key":"R18-18-20210128","first-page":"1606","article-title":"Concurrent temporal (giant cell) arteritis and malignancy: report of 20 patients with review of the literature","volume":"33","author":"Liozon","year":"2006","journal-title":"J Rheumatol"},{"key":"R19-18-20210128","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archderm.143.1.89","article-title":"Relapsing polychondritis and malignant lymphoma: is polychondritis paraneoplastic?","volume":"143","author":"Yanagi","year":"2007","journal-title":"Arch Dermatol"},{"key":"R20-18-20210128","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/art.10939","article-title":"Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives","volume":"48","author":"Ekstrom","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R21-18-20210128","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/01.bor.0000209423.39033.94","article-title":"Malignancy and autoimmunity","volume":"18","author":"Bernatsky","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"R22-18-20210128","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/0959-8049(96)00210-9","article-title":"Rheumatoid arthritis and cancer risk","volume":"32A","author":"Mellemkjaer","year":"1996","journal-title":"Eur J Cancer"},{"key":"R23-18-20210128","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jnci\/85.4.307","article-title":"Incidence of cancer among patients with rheumatoid arthritis","volume":"85","author":"Gridley","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"R24-18-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000071364","article-title":"Epidemiology of nonsteroidal anti-inflammatory drugs and cancer","volume":"37","author":"Baron","year":"2003","journal-title":"Prog Exp Tumor Res"},{"key":"R25-18-20210128","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/ard.2004.033241","article-title":"Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists","volume":"64","author":"Askling","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R26-18-20210128","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/art.20311","article-title":"Lymphoma in rheumatoid arthritis: the effect of methotrexate and antitumor necrosis factor therapy in 18,572 patients","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R27-18-20210128","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/jnci\/djj361","article-title":"Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia","volume":"98","author":"Landgren","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R28-18-20210128","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/1529-0131(200004)43:4<908::AID-ANR24>3.0.CO;2-K","article-title":"Salivary gland lymphomas in patients with Sj\u00f6gren's syndrome may frequently develop from rheumatoid factor B cells","volume":"43","author":"Martin","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R29-18-20210128","first-page":"416","article-title":"Hepatitis C and B cells: induction of autoimmunity and lymphoproliferation may reflect chronic stimulation through cell-surface receptors","volume":"31","author":"Starkebaum","year":"2004","journal-title":"J Rheumatol"},{"key":"R30-18-20210128","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1182\/blood-2005-04-1722","article-title":"Influence of antigen on the development of MALT lymphoma","volume":"107","author":"Lenze","year":"2006","journal-title":"Blood"},{"key":"R31-18-20210128","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V99.11.3909","article-title":"Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France","volume":"99","author":"Mariette","year":"2002","journal-title":"Blood"},{"key":"R32-18-20210128","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"54","author":"Baecklund","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R33-18-20210128","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.20061531","article-title":"Anti-TNF-{alpha} therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-{beta}","volume":"204","author":"Nadkarni","year":"2007","journal-title":"J Exp Med"},{"key":"R34-18-20210128","first-page":"S033","article-title":"Can remission be maintained with or without further drug therapy in rheumatoid arthritis?","volume":"24","author":"Saleem","year":"2006","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl","key":"R35-18-20210128","first-page":"S302","article-title":"Remission induction in early rheumatoid arthritis with initial infliximab and methotrexate therapy: The Disease Course After IFX Discontinuation in The BeSt Trial [abstract]","volume":"54","author":"Van Der Kooij","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R36-18-20210128","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"R37-18-20210128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.21519","article-title":"The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment","volume":"54","author":"Breedveld","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R38-18-20210128","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/art.21029","article-title":"An international cohort study of cancer in SLE","volume":"52","author":"Bernatsky","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R39-18-20210128","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/art.21225","article-title":"Risk of malignancy in scleroderma: a population-based cohort study","volume":"52","author":"Chatterjee","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R40-18-20210128","first-page":"637","article-title":"Increased incidence of carcinoma of the tongue in patients with systemic sclerosis","volume":"32","author":"Derk","year":"2005","journal-title":"J Rheumatol"},{"key":"R41-18-20210128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jnci\/djj004","article-title":"Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype","volume":"98","author":"Smedby","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R42-18-20210128","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.ejca.2006.04.021","article-title":"Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in Sweden","volume":"42","author":"Soderberg","year":"2006","journal-title":"Eur J Cancer"},{"key":"R43-18-20210128","first-page":"888","article-title":"Angioimmunoblastic T-cell lymphoma: a relatively common type of T-cell lymphoma in Sjogren's syndrome","volume":"23","author":"Saito","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"R44-18-20210128","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1136\/ard.2005.047514","article-title":"Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study","volume":"65","author":"Askling","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R45-18-20210128","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1001\/jama.297.17.1923","article-title":"Translating MicroRNA Discovery Into Clinical Biomarkers in Cancer","volume":"297","author":"Waldman","year":"2007","journal-title":"JAMA"},{"key":"R46-18-20210128","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1191\/0961203304lu521oa","article-title":"Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes","volume":"13","author":"Solans-Laque","year":"2004","journal-title":"Lupus"},{"key":"R47-18-20210128","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1191\/0961203304lu1080oa","article-title":"Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients","volume":"13","author":"Ramos-Casals","year":"2004","journal-title":"Lupus"},{"key":"R48-18-20210128","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/01.md.0000157398.37679.47","article-title":"Circulating monoclonal immunoglobulins in Sj\u00f6gren syndrome: prevalence and clinical significance in 237 patients","volume":"84","author":"Brito-Zeron","year":"2005","journal-title":"Medicine"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0b013e3282f1ecd4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T18:56:19Z","timestamp":1620932179000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-200801000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e3282f1ecd4","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}